D‐penicillamine–induced polymyositis in patients with rheumatoid arthritis | Zendy

Takahashi Koki | Zendy; Ogita Tadaatsu | Zendy; Okudaira Hirokazu | Zendy; Yoshinoya Sadayoshi | Zendy; Yoshizawa Hisayoshi | Zendy; Miyamoto Terumasa | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

D‐penicillamine–induced polymyositis in patients with rheumatoid arthritis

Author(s) -

Takahashi Koki,

Ogita Tadaatsu,

Okudaira Hirokazu,

Yoshinoya Sadayoshi,

Yoshizawa Hisayoshi,

Miyamoto Terumasa

Publication year - 1986

Publication title -

arthritis & rheumatism

Language(s) - English

Resource type - Journals

eISSN - 1529-0131

pISSN - 0004-3591

DOI - 10.1002/art.1780290416

Subject(s) - polymyositis , rheumatoid arthritis , medicine , dermatomyositis , penicillamine , incidence (geometry) , complication , dermatology , physics , optics

Among 329 patients with rheumatoid arthritis treated with D‐penicillamine (DP), we found 4 cases of polymyositis. This incidence was significantly higher than the expected coincidence of rheumatoid arthritis and polymyositis/dermatomyositis or than the presumed frequency of this complication among patients treated with DP. In the present report, we summarize and discuss the clinical findings in DP‐induced polymyositis/dermatomyositis in our patients and others described in the literature.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research